An abnormal Mini-Mental State Examination (MMSE) should lead to a fuller clinical evaluation, not an immediate dementia diagnosis. Next steps may include detailed cognitive testing, a medical review, laboratory tests, brain imaging, and sometimes specialist assessment. The MMSE is a brief screen of cognitive abilities. Its result can show that more investigation is needed, but it cannot establish the cause, severity, or type of impairment by itself.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does an abnormal MMSE result mean?
- What happens during the fuller evaluation?
- Which other causes must be checked?
- When are CT, MRI, or biomarkers useful?
- How can you prepare for the next appointment?
What does an abnormal MMSE result mean?
An abnormal result suggests that the person had difficulty with one or more tasks on the screen. It does not prove that the person has mild cognitive impairment (MCI), Alzheimer disease, or another dementia. The Alzheimer's Association cognitive-assessment guidance recommends further evaluation or specialist referral before making such a diagnosis. The score also needs context.
The cutoff used and the person's education can affect accuracy. In community studies using a cutoff score of 24, a Cochrane review reported 85% sensitivity and 90% specificity. That means the MMSE can miss some people with dementia and incorrectly flag some people without it. Clinicians therefore interpret the result alongside symptoms, daily functioning, medical history, and other tests. A score is one piece of evidence, not the final answer.
What happens during the fuller evaluation?
The clinician asks when cognitive changes began, how they have progressed, and whether they interfere with usual activities. When possible, a family member or another person who knows the patient well provides additional information.
The clinician also reviews medical conditions and every medication being taken. More detailed testing may examine: According to the National Institute on Aging's diagnostic overview, this combination of history, informant input, medication review, and cognitive testing helps characterize the impairment. It can show whether the mmse result matches a broader pattern of cognitive change.
- Memory
- Attention
- Language
- Problem-solving
Which other causes must be checked?
Cognitive symptoms do not always come from a progressive dementia. Stroke, infection, sleep problems, medication effects, tumors, and other medical conditions can cause or worsen them. The work-up may include blood, urine, and other standard medical tests. Clinicians may also assess for depression or another mental-health condition.
These checks matter because an abnormal screen cannot reveal what is producing the symptoms. Primary-care clinicians often refer patients when the presentation is inconclusive or unusual. Referral is also common for behavioral or psychiatric symptoms, symptoms beginning before age 65, or a requested second opinion. Depending on the concern, the patient may see a neurologist, neuropsychologist, or geriatric specialist.
When are CT, MRI, or biomarkers useful?
CT and MRI provide structural images of the brain. They can help identify atrophy and exclude problems such as bleeding, excess fluid, tumors, clots, or vascular injury. MRI-detected shrinkage may support evidence of neurodegeneration, but it cannot identify a particular dementia by itself. If Alzheimer disease remains a concern after the clinical evaluation, a specialist may consider amyloid PET imaging, cerebrospinal fluid tests for amyloid and tau, or an appropriate blood biomarker.
The National Institute on Aging's biomarker guidance emphasizes that no single biomarker independently diagnoses Alzheimer disease or a related dementia. Amyloid PET results require especially careful interpretation. A positive scan can occur in someone who has plaques but never develops Alzheimer symptoms. A scan showing few or no plaques usually indicates that Alzheimer disease is not causing the person's symptoms.
How can you prepare for the next appointment?
Bring information that helps the clinician connect the MMSE result with real-world changes. Useful preparation includes: Ask what the MMSE result does—and does not—show, which possible causes are being investigated, and whether specialist testing would change the next decision. If imaging or a biomarker is proposed, ask how the result will be interpreted alongside symptoms and functional history.
- A complete medication list
- Notes about when symptoms began and whether they have changed
- Examples of difficulties with usual daily activities
- Relevant medical and mental-health history
- A trusted person who can describe changes they have observed
